The FDA has approved Ctexli for the treatment of cerebrotendinous xanthomatosis (CTX), a rare lipid storage disease, in ...
Chenodiol -- a naturally occurring human bile acid also known as chenodeoxycholic acid -- is the first FDA-approved drug ...
The FDA on Friday approved Mirum Pharmaceuticals' Ctexli to treat adults with cerebrotendinous xanthomatosis (CTX), a rare, progressive and genetic disease.
The Food and Drug Administration approved Mirum Pharmaceuticals' Ctexli to treat Cerebrotendinous Xanthoma, a very rare lipid-storage disease. The approval makes Ctexli, or chenopod, the first ...
A combination of mRNA and a new lipid nanoparticle could help heal damaged lungs, according to new research from the Perelman ...
The concept of using vaccines to treat cancers has been around for several decades. A vaccine was first approved for prostate cancer in 2010, and another was approved in 2015 for melanoma. Since then, ...
The following is a summary of “Association between Life’s Essential 8 and Atherogenic Index of Plasma in adults: insights ...
The supplement tricaprin, which is found in coconut or MCT oil, improved long-term survival for people with triglyceride ...
A man in his 40s experienced "asymptomatic yellowish nodules on his palms, soles, and elbows" for three weeks.
Oligonucleotide therapies are among the most promising biological therapeutics. They target disease at a different stage of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback